Biomarkers Market - Trends Forecast Till 2028

Biomarkers Market by Product (Consumable, Service), Type (Safety, Efficacy, Validation), Disease (Cancer (Solid & Liquid Biopsy), Neurological), Application (Diagnostics, Drug Discovery & Development, Personalized Medicine), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: November, 2021

Base Year Estimate: 2020

Report ID: D-PH-BM-388

Format:  

Number of Pages: 253

Domain: Pharmaceutical

Biomarkers Market – Trends Forecast Till 2028

The global biomarkers market size was valued at USD 43.1 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2021 to 2028.

Diagnostic biomarkers are minimally or non-invasive tools. Biomarkers, integrated with key imaging and data management technologies, is meeting the market expectations; however, has set backs too. Biomarkers are used in imaging technology to provide clear imaging of oncology tumours and other problems and also eliminate chance of radiation exposure during imaging through CT scan and MRI scan.

The growing importance of companion diagnostics, increasing prevalence of cancer worldwide, increasing funds & grants for biomarker research, and continuous product innovations are some of the factors that have supported long-term expansion for Biomarkers Market.

Many biomarkers are also playing an important role in the diagnosis of COVID-19. Biomarkers such as C-reactive protein, serum amyloid A, interleukin-6, lactate dehydrogenase, neutrophil-to-lymphocyte ratio, D-dimer, cardiac troponin, renal biomarkers, lymphocytes and platelet count. These markers showed significantly higher levels in patients with severe complications of COVID-19 infection compared to their non-severe counterparts.

Biomarkers Market Analysis

North America accounted for the largest share of the market. The large share of this region can be attributed to the growing use of biomarkers in personalized medicine, various growth strategies adopted by key players with established pharmaceutical companies in this region, and a higher adoption rate of biomarkers for disease diagnostics, majorly in cancer diagnosis

Biomarkers Market is segmented into product & services, type, application, disease indication and region.

On the basis of Product

  • Consumables
  • Services
  • Software

On the basis of Type

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Predictive Biomarkers
  • Surrogate Biomarkers
  • Pharmacodynamics Biomarkers
  • Prognostic Biomarkers
  • Validation Biomarkers

On the basis of Application  

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Disease Risk Assessment

On the basis of Disease Infection

  • Infectious Diseases
  • Immune Disorders
  • Neurological Disorders
  • Cardiovascular Disorders
  • Cancer by test type

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Biomarkers Market Primary respondent

 

Key Players

  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Enzo Biochem, Inc.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific

Recent Developments

  • In April 2021, F. Hoffmann-La Roche Ltd. (Switzerland) launched two cardiac biomarker tests for high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These gold standard biomarkers support cardiovascular disease management and can help clinicians diagnose heart attacks and manage heart failure better.
  • In May 2021, QIAGEN N.V. (Netherlands) launched the first FDA-approved tissue companion diagnostic, therascreen KRAS RGQ PCR Kit, to identify the KRAS G12C mutation in NSCLC tumors and expand precision medicine options in lung cancer.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Biomarkers Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 43.1 billion

Growth Rate

CAGR of 12.6% during the forecasting period, 2021-2026

Historical Data

2018-2019

Forecast Years

2021-2026

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2026

Report Segmentation

product & services, type, application, disease indication and region.

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, QIAGEN N.V., PerkinElmer, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., Charles River Laboratories International, Inc. and Eurofins Scientific.

Available Customization

In addition to the market data for Biomarkers Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.